Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. 1979

J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl

A patient suffering from chronic active hepatitis with macronodular cirrhosis, positive for hepatitis B surface antigen (HBsAg), was treated with an orthotopic liver allograft. The HBs antigenemia, as measured with several precipitation tests and by complement fixation, became negative after transplantation and remained so for about 2 1/2 months. During the interval, very low titers of the antigen were detectable by radioimmunoassay. At about three months after transplantation, she had an attack of acute hepatitis, at which time HBsAg became detectable by all tests. She recovered, but progressive liver disease developed during the remaining 1 1/2 years of her life. She died of disseminated nocardiosis and candidiasis with deteriorating hepatic function. The homograft at autopsy showed no evidence of rejection, but was the site of chronic active liver disease, although of a different pathologic pattern than that affecting her native liver. The differences in histology may reflect the influence of chronic immunosuppression on the features of chronic active hepatitis.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
May 1978, Sovetskaia meditsina,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
September 1985, Journal of the Indian Medical Association,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
June 1976, Srpski arhiv za celokupno lekarstvo,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
August 1986, Journal of the Tennessee Medical Association,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
December 1984, Gastroenterology,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
July 2021, The Journal of infectious diseases,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
January 1977, JAMA,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
January 1977, Terapevticheskii arkhiv,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
January 1979, Arkhiv patologii,
J L Corman, and C W Putnam, and S Iwatsuki, and A G Redeker, and K A Porter, and R L Peters, and G Schröter, and T E Starzl
January 1988, Journal of pediatric gastroenterology and nutrition,
Copied contents to your clipboard!